Casdin Capital LLC 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 9:27 pm Sale | 2022-12-31 | 13G | VERVE THERAPEUTICS INC VERV | Casdin Capital LLC | 2,290,571 3.700% | -847,596 (-27.01%) | Filing |
| 2022-02-14 09:27 am Purchase | 2021-12-31 | 13G | VERVE THERAPEUTICS INC VERV | Casdin Capital LLC | 3,138,167 6.500% | 100,000 (+3.29%) | Filing |